Hyperbaric oxygen therapy in Quebec

Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante
Record ID 32002000319
English, French
Authors' objectives:

This report aims to: - describe hyperbaric oxygen (HBO) therapy and its mechanisms of action - systematically review the scientific literature in order to determine which pathologies and in what conditions HBO therapy is effective - review the adverse effects and complications of HBO therapy - examine the risks associated with operating a hyperbaric chamber and the necessary safety measures relating thereto. - estimate the potential demand for HBO therapy in Quebec and the costs that would be generated in meeting this demand - define the guidelines for meeting this potential demand, if applicable.

Authors' recommendations: Although HBO therapy has been tried out on nearly 130 medical conditions, it is CETS's conclusion that this technology can be recommended for only 13 of them. Its efficacy in the treatment of cerebral palsy, although not demonstrated, is still controversial, gviven the results of an RCT recently conducted in Quebec. CETS also believes that the potential demand justifies installing hyperbaric chambers in the Greater Quebec City Area and gradually installing others in the Greater Montreal Area. These decisions would lead to considerable expenses that would probably be offset by the decrease in the lengths of hospital stay for chronic cases. Studies would be necessary in order to validate the clinical and administrative efficacy. Lastly steps would need to be taken to ensure the presence of a multidisciplinary team, permanent medical supervision and compliance with safety standards.
Authors' methods: Review
Project Status: Completed
Year Published: 2000
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Hyperbaric Oxygenation
  • Oxygen Inhalation Therapy
Organisation Name: Agence d'évaluation des technologies et des modes d'intervention en santé
Contact Address: 2021, avenue Union, Bureau 10.083,Montreal, Quebec H3A S29, Canada.Tel: +1 514 873 2563; Fax: +1 514 873 1369
Contact Name: demande@inesss.qc.ca
Contact Email: demande@inesss.qc.ca
Copyright: Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante (AETMIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.